USPTO serial 79165788
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $1,700
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lori A. Ruhly
Lori A. Ruhly Quarles & Brady LLP33 East Main Street, Suite 900Madison, WI 53703United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemicals for use in the pharmaceutical industry; chemical substances for preserving foodstuffs; chemicals for use in the manufacture of pharmaceuticals for the treatment of angiologic disorders, particularly varicose veins; chemicals for use in the production of injectable foams ] | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical preparations for the treatment of varicose veins and arterio-venous malformations; pharmaceutical preparations for the treatment of vascular diseases; pharmaceutical products and preparations to prevent swelling in the legs; sanitary preparations for medical purposes; [ dietary supplements for humans and animals; medical plasters; materials for dressings, namely, adhesive bandages, medical and surgical adhesive tape; ] medical dressings; surgical dressings; wound dressings; pharmaceutical preparations in the form of foams and for use in preparing foams, for sclerotherapy, phlebology, angiology [ and proctology, for treatment of oesophageal varices, hydroceles, ] in sterilization treatment and for treatment of varicose veins, and arterio-venous malformations | ACTIVE | — |
| 010 | * Surgical and medical apparatus for use in the treatment of varicose veins, arterio-venous malformation [, oesophageal varices and hydroceles ]; surgical and medical apparatus for use in sclerotherapy, phlebology, angiology [ and proctology, and for the treatment of oesophageal varices, hydroceles ], in sterilization treatment and for the treatment of varicose veins, and arterio-venous malformations; * Medical syringes; [ cannula needles for medical use; ] * medical tubing for administration of foams for sclerotherapy; medical tubing for administration of foams for the treatment of varicose veins, venose malformations,* and * arterio-venous malformations [, oesophageal varices and hydroceles ] ; * surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, * and * arterio-venous malformations [, oesophageal varices and hydroceles ] ; surgical and medical apparatus for producing and administering foams for use in sterilization treatment; surgical and medical apparatus for producing foams for use in sclerotherapy, phlebology, angiology and proctology, sterilization treatment and for * [ the ] * treatment of varicose veins, arterio-venous malformations, [ oesophageal varices and hydroceles; ] none of the aforementioned goods being supportive bandages or compression bandages; medical devices, namely, devices for assessing the physical characteristics of foams for use in sclerotherapy, phlebology, angiology and proctology, sterilization treatment and for treatment of varicose veins, * and * arterio-venous malformations, [ oesophageal varices and hydroceles, ] devices for intravenous administration of such foam [, and devices for monitoring the position and effect of such foam in the human body; medical diagnostic devices for use in all the above medical conditions ] | ACTIVE | — |
| 042 | [ Design and development of computer hardware and software; computer programming; installation, maintenance and repair of computer software; computer consultancy services; scientific research services related to sclerotherapy of veins including provision of treatment in the fields of phlebology, proctology and angiology ] | SECTION 71 - CANCELLED | — |
| 044 | [ Medical services; hygienic and beauty care for human beings or animals; medical analysis for the diagnosis and treatment of persons in the fields of sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; pharmaceutical advice; medical services for diagnosis in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical health assessment services, namely, providing post-treatment and homecare to patients in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical treatment services in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical after-care services in the fields of sclerotherapy, phlebology, angiology and proctology and, in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment ] | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 19, 2026 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Aug 19, 2026 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Aug 10, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 4, 2026 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| May 3, 2025 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Dec 13, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 3, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 3, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 3, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 3, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 26, 2024 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jun 28, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Mar 17, 2024 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 2, 2024 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 2, 2024 | INPC | INVALIDATION PROCESSED | — |
| Jan 20, 2024 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 23, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 22, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 22, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 22, 2023 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| May 22, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 22, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 22, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 20, 2023 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| May 20, 2023 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| May 20, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 2, 2022 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jan 8, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 3, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 13, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 28, 2017 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Mar 22, 2017 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 17, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 9, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 9, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 3, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 22, 2016 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Jul 22, 2016 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jul 22, 2016 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| May 3, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 29, 2016 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Mar 4, 2016 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Feb 16, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 16, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 13, 2016 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 27, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 27, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 27, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 13, 2016 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jan 13, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 13, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 13, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 12, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 12, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 7, 2016 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jan 3, 2016 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Dec 11, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 9, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 9, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 4, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 12, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 12, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 12, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 11, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 6, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 2, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 2, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 30, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |